Stock PAREXEL INTERNATIONAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News PAREXEL International Corporation

Equities

US6994621075

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Parexel : Launches Enhanced Integrated Functional Service Provider Model to Drive Delivery of Innovative Clinical Research Partnerships
BU
PAREXEL International : Launches Perceptive® Cloud for the Life Sciences Industry
BU
PAREXEL International : Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry
BU
PAREXEL International : Pamplona Capital Management Completes Acquisition of PAREXEL International
BU
PAREXEL International : Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management
BU
PAREXEL International : Medical Research Stock Performance Review -- Exact Sciences, DexCom, and PAREXEL
PR
PAREXEL International : Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments
BU
PAREXEL International : Reports Fourth Quarter and Fiscal Year 2017 Results
BU
PAREXEL International : Announces Date of Fourth Quarter and Fiscal Year 2017 Earnings Release
BU
PAREXEL International : and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan
BU
PAREXEL International Corporation : Announces $720 Million Senior Notes Offering by West Street Merger Sub, Inc.
BU
PAREXEL International : Two PAREXEL Executives Named to 2017 PharmaVOICE 100
BU
PAREXEL International : Receives CEO Cancer Gold Standard Re-Accreditation
BU
PAREXEL International : Named to the Forbes America’s Best Employers List for Second Consecutive Year
BU
Brower Piven Commences an Investigation into the Proposed Sale of PAREXEL International Corporation and Encourages Investors to Contact the Firm for Additional Information
BU
PAREXEL INTERNATIONAL CORPORATION Former SEC Attorney Willie Briscoe Investigates Sale to Pamplona Capital Management, LLP
BU
PAREXEL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PAREXEL International Corporation
PR
PAREXEL International : Pamplona Capital to take Parexel private for $4.5 billion
RE
PAREXEL International : Pamplona Capital to take Parexel private for $4.5 billion
RE
PAREXEL International : Enters Definitive Agreement to Be Acquired by Pamplona Capital Management for $88.10 Per Share in Cash
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News PAREXEL International Corporation